Abstract
This study was designed to test the hypothesis that T-cell effector mechanisms are required for protective immunity to malaria sporozoites. Administration of neutralizing monoclonal antibodies against γ interferon (γIFN) to immune hosts, reversed sterile immunity to sporozoite challenge, by allowing the growth of exoerythrocytic forms (EEF) and thus the development of parasitaemia. Immune animals also developed infections when depleted in vivo of their suppressor/cytotoxic T cells expressing the CD8 antigen (CD8+) but not when depleted of helper T cells expressing CD4 antigen (CD4+), before sporozoite challenge. Passive transfer of immune immunoglobin alone, or adoptive transfer of immune T cells alone, conferred partial protection to naive recipients. Transfer of both immune components resulted in significantly greater protection. This transferred immunity was reversed by the in vivo neutralization of γIFN. Thus, sterile immunity to sporozoite challenge requires the neutralization of sporozoites by antibodies and the inhibition of EEF development by γIFN with the participation of CD8+ cells.
Similar content being viewed by others
References
1. Nussenzweig, R. & Nussenzweig, V. Phil Trans R. Soc. B307, 117-128 (1984). 2. Zavala, F., Cochrane, A., Nardin, E., Nussenzweig, R. & Nussenzweig, V. J. exp. Med. 157, 1947-1957 (1983). 3. Potocjnack, P., Yoshida, N., Nussenzweig, R. & Nussenzweig, V. J. exp. Med. 151,1504-1513 (1980). 4. Hollingdale, M., Zavala, F., Nussenzweig, R. & Nussenzweig, V. J. Immun. 128, 1929-1930 (1982). 5. Chen, D., Tigelaar, R. & Weinbaum, F. /. Immun. 118, 1322-1327 (1977). 6. Ferreira, A. et al. Science 232, 881-884 (1986). 7. Maheshwari, R. et al. Infect. Immunity 53, 628-630 (1986). 8. Schofield, L., Ferreira, A., Altszuler, R., Nussenzweig, V. & Nussenzweig, R. S. J. Immun. 139,2020-2025 (1987). 9. Van Der Meide, P. et al. J. gen. Virol. 67, 1059 (1986). 10. Ferreira, A., Enea, V., Morimoto, T. & Nussenzweig, V. Molec. Biochem. Parasitol. 19, 103-109 (1986). 11. Shin, S.. Vanderberg, J. & Terzakis, J. / Protozool. 29(3), 448-454 (1982). 12. Hamilton Fairley, N. Trans. R. Soc. trap. Med. Hyg. 40, 621-676 (1947). 13. Cobbold, S., Jayasuriya, A., Nash, A., Prospero, T. & Waldmann, H. Nature 312, 548-551 (1984). 14. Verhave, J., Strickland, G., Jaffe, H. & Ahmad, A. J. Immun. 121, 1031-1033 (1978). 15. Egan, J. et al. Science 236, 453-456 (1987). 16. Zavala, F. et al. J. exp. Med. 166, 1591-1596 (1987). 17. Good, M. et al. Science 235, 1059-1062 (1976). 18. Good, M. et al. J. exp. Med. 164, 655-660 (1986). 19. Del Guidice, G. et al. J. Immun. 137, 2952-2955 (1986). 20. Togna, A. et al. J. Immun. 137, 2956-2960 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schofield, L., Villaquiran, J., Ferreira, A. et al. γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664–666 (1987). https://doi.org/10.1038/330664a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/330664a0
- Springer Nature Limited
This article is cited by
-
A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion
EMBO Molecular Medicine (2024)
-
Cytolytic circumsporozoite-specific memory CD4+ T cell clones are expanded during Plasmodium falciparum infection
Nature Communications (2023)
-
mRNA vaccine against malaria tailored for liver-resident memory T cells
Nature Immunology (2023)
-
Efficient infection of non-human primates with purified, cryopreserved Plasmodium knowlesi sporozoites
Malaria Journal (2022)
-
Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa
Nature Communications (2022)